journal article·2019-03-26

Vibrational Circular Dichroism Reveals Supramolecular Chirality Inversion of α-Synuclein Peptide Assemblies upon Interactions with Anionic Membranes

Benjamin Martial, Thierry Lefèvre, Thierry Buffeteau, Michèle Auger

ACS Nano· Volume 13· Issue 3
Publisher page

Abstract

Parkinson’s disease is an incurable neurodegenerative disorder caused by the aggregation of α-synuclein (AS). This amyloid protein contains a 12-residue-long segment, AS71–82, that triggers AS pathological aggregation. This peptide is then essential to better understand the polymorphism and the dynamics of formation of AS fibrillar structures. In this work, vibrational circular dichroism showed that AS71–82 is random coil in solution and forms parallel β-sheet fibrillar aggregates in the presence of anionic vesicles. Vibrational circular dichroism, with transmission electronic microscopy, revealed that the fibrillar structures exhibit a nanoscale tape-like morphology with a preferential supramolecular helicity. Whereas the structure handedness of some other amyloid peptides has been shown to be driven by pH, that of AS71–82 is controlled by peptide concentration and peptide-to-lipid (P:L) molar ratio. At low concentrations and low P:L molar ratios, AS71–82 assemblies have a left-twisted handedness, whereas at high concentrations and high P:L ratios, a right-twisted handedness is adopted. Left-twisted assemblies interconvert into right-twisted ones with time, suggesting a maturation of the amyloid structures. As fibril species with two chiralities have also been reported previously in Parkinson’s disease Lewy bodies and fibrils, the present results seem relevant to better understand AS amyloid assembly and fibrillization in vivo. From a diagnosis or therapeutic point of view, it becomes essential that future fibril probes, inhibitors, or breakers target pathological assemblies with specific chirality and morphology, in particular, because they may change with the stage of the disease.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Alzheimer's disease research and treatments · Supramolecular Self-Assembly in Materials · Parkinson's Disease Mechanisms and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, Regroupement québécois de recherche sur la fonction, l’ingénierie et les applications des protéines (PROTEO), Centre de recherche sur les matériaux avancés (CERMA), Centre québécois sur les matériaux fonctionnels (CQMF), Université Laval, Québec, QC G1 V 0A6, Canada

Université Bordeaux, Institut des Sciences Moléculaires, CNRS UMR 5255, 33405 Talence, France

Funding

Universit? Laval · Natural Sciences and Engineering Research Council of Canada · Fonds de Recherche du Qu?bec - Nature et Technologies

References (75)

Show source-provided references
1. 10.1016/0896-6273(95)90302-X10.1016/0896-6273(95)90302-X ↗
2. 10.1073/pnas.95.11.646910.1073/pnas.95.11.6469 ↗
3. 10.1038/4216610.1038/42166 ↗
4. 10.1146/annurev-biochem-061516-04511510.1146/annurev-biochem-061516-045115 ↗
5. 10.1176/jnp.14.2.22310.1176/jnp.14.2.223 ↗
6. 10.3390/ijms1706090410.3390/ijms17060904 ↗
7. 10.1016/j.metabol.2014.10.03010.1016/j.metabol.2014.10.030 ↗
8. 10.1016/j.neuron.2015.03.01710.1016/j.neuron.2015.03.017 ↗
9. 10.1073/pnas.180419811510.1073/pnas.1804198115 ↗
10. 10.1074/jbc.M111.31894910.1074/jbc.M111.318949 ↗
11. 10.1038/nature1653110.1038/nature16531 ↗
12. 10.1021/bi961799n10.1021/bi961799n ↗
13. 10.1074/jbc.273.16.944310.1074/jbc.273.16.9443 ↗
14. 10.1006/jmbi.2001.453810.1006/jmbi.2001.4538 ↗
15. 10.1038/ncomms482710.1038/ncomms4827 ↗
16. 10.1523/JNEUROSCI.4650-14.201510.1523/JNEUROSCI.4650-14.2015 ↗
17. 10.1074/jbc.M21013620010.1074/jbc.M210136200 ↗
18. 10.1088/1478-3975/6/1/01500510.1088/1478-3975/6/1/015005 ↗
19. 10.1021/ja209019s10.1021/ja209019s ↗
20. 10.1038/srep0922810.1038/srep09228 ↗
21. 10.1021/ar400016810.1021/ar4000168 ↗
22. 10.1038/nsmb.319410.1038/nsmb.3194 ↗
23. 10.1021/jacs.7b0740310.1021/jacs.7b07403 ↗
24. 10.1021/bi020429y10.1021/bi020429y ↗
25. 10.1073/pnas.90.23.1128210.1073/pnas.90.23.11282 ↗
26. 10.1016/S0002-9440(10)65220-010.1016/S0002-9440(10)65220-0 ↗
27. 10.1074/jbc.M00891920010.1074/jbc.M008919200 ↗
28. 10.1523/JNEUROSCI.0285-07.200710.1523/JNEUROSCI.0285-07.2007 ↗
29. 10.1038/srep3601010.1038/srep36010 ↗
30. 10.1021/bi500870710.1021/bi5008707 ↗
31. 10.1007/s12551-018-0427-210.1007/s12551-018-0427-2 ↗
32. 10.1111/j.1742-4658.2005.05022.x10.1111/j.1742-4658.2005.05022.x ↗
33. 10.4161/pri.1.1.409510.4161/pri.1.1.4095 ↗
34. 10.1073/pnas.263488410010.1073/pnas.2634884100 ↗
35. 10.1016/j.bbamem.2015.01.01810.1016/j.bbamem.2015.01.018 ↗
36. 10.1038/nchembio.175010.1038/nchembio.1750 ↗
37. 10.1073/pnas.161058611410.1073/pnas.1610586114 ↗
38. 10.1021/bi012090610.1021/bi0120906 ↗
39. 10.1016/j.saa.2016.07.01510.1016/j.saa.2016.07.015 ↗
40. 10.1016/j.bbamem.2013.12.00510.1016/j.bbamem.2013.12.005 ↗
41. 10.1016/j.ab.2012.03.02310.1016/j.ab.2012.03.023 ↗
42. 10.1021/ja074188z10.1021/ja074188z ↗
43. 10.1002/bip.2022710.1002/bip.20227 ↗
44. 10.1016/j.sbi.2012.03.00210.1016/j.sbi.2012.03.002 ↗
45. 10.1110/ps.023780310.1110/ps.0237803 ↗
46. 10.1002/bip.36031140910.1002/bip.360311409 ↗
47. 10.1002/bip.36025091510.1002/bip.360250915 ↗
48. 10.1016/j.bbabio.2007.06.00410.1016/j.bbabio.2007.06.004 ↗
49. 10.1038/srep4105110.1038/srep41051 ↗
50. 10.1110/ps.9.10.196010.1110/ps.9.10.1960 ↗
51. 10.1021/ja407583r10.1021/ja407583r ↗
52. 10.1039/c3cp44623a10.1039/c3cp44623a ↗
53. 10.1016/j.bbapap.2012.08.01010.1016/j.bbapap.2012.08.010 ↗
54. 10.1038/srep3202210.1038/srep32022 ↗
55. 10.3233/JPD-17110310.3233/JPD-171103 ↗
56. 10.1021/cn300024710.1021/cn3000247 ↗
57. 10.1021/ja108982710.1021/ja1089827 ↗
58. 10.1021/jp405612610.1021/jp4056126 ↗
59. 10.1021/acs.jpcb.5b0477910.1021/acs.jpcb.5b04779 ↗
60. 10.1016/S0022-2836(02)00775-110.1016/S0022-2836(02)00775-1 ↗
61. 10.1073/pnas.071217910510.1073/pnas.0712179105 ↗
62. 10.1038/ncomms357510.1038/ncomms3575 ↗
63. 10.4161/pri.3.2.885910.4161/pri.3.2.8859 ↗
64. 10.1126/science.110585010.1126/science.1105850 ↗
65. 10.1002/mrc.134110.1002/mrc.1341 ↗
66. 10.1002/anie.20130917210.1002/anie.201309172 ↗
67. 10.1021/nn406121w10.1021/nn406121w ↗
68. Kurouski D. · 2016 · 73
69. 10.1126/science.117825010.1126/science.1178250 ↗
70. 10.1529/biophysj.104.04884310.1529/biophysj.104.048843 ↗
71. 10.1039/c2cc16895b10.1039/c2cc16895b ↗
72. 10.1083/jcb.100.6.190510.1083/jcb.100.6.1905 ↗
73. 10.1021/nn404886k10.1021/nn404886k ↗
74. 10.1021/ja066703j10.1021/ja066703j ↗
75. 10.1366/000370205428056810.1366/0003702054280568 ↗